Rating History for CytoMed Therapeutics (GDTC) by StoneX

More Stocks Rated by StoneX | Latest Ratings for GDTC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/21/2023 Bruce Jackson New Coverage Speculative Buy
(N/A)		 5.00
(N/A)		 3.85
(0.81)		 -78.96% Details